P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY

Detalles Bibliográficos
Autores principales: Terpos, E, Ntanasis-Stathopoulos, I, Kastritis, E, Hatjiharissi, E, Katodritou, E, Eleutherakis-Papaiakovou, E, Verrou, E, Gavriatopoulou, M, Leonidakis, A, Delimpasi, S, Malandrakis, P, Kyrtsonis, M-C, Papaioannou, M, Symeonidis, A, Dimopoulos, MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012123/
http://dx.doi.org/10.1097/01.HS9.0000829636.39178.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012123/
http://dx.doi.org/10.1097/01.HS9.0000829636.39178.19

Ejemplares similares